InsiderTrades

Form 4 for HIMS Hims & Hers Health, Inc.

Accepted 2024-07-16 00:00:00 ET · period of report 2024-07-12 · accession 0001773751-24-000225 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-07-16 2024-07-12 HIMS Chi Michael Chief Commercial Off M - OptEx $7.86 +9,313 194.6K +5% +$73.2K
D 2024-07-16 2024-07-12 HIMS Chi Michael Chief Commercial Off S - Sale+OE $22.00 -9,313 185.3K -5% -$204.9K
DM 2024-07-16 2024-07-12 HIMS Chi Michael Chief Commercial Off M - OptEx $0.00 -9,313 181.5K -5% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2024-07-12 M A 2,054 $11.53 187,380 D — —
2 Common Class A Common Stock 2024-07-12 M A 7,259 $6.82 194,639 D — —
3 Common Class A Common Stock 2024-07-12 S D 9,313 $22.00 185,326 D — —
4 Derivative Stock Option (right to buy) 2024-07-12 M D 2,054 $0.00 65,736 D $11.53 · — to 2033-03-01 2,054 Class A Common Stock (F2) The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting monthly, beginning on April 1, 2023.
5 Derivative Stock Option (right to buy) 2024-07-12 M D 7,259 $0.00 181,475 D $6.82 · — to 2032-08-10 7,259 Class A Common Stock (F3) The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting on September 10, 2022, and 1/48th of the options vesting monthly thereafter.